Phase I study of everolimus (RAD001) with irinotecan (Iri) and cetuximab (C) in second-line metastatic colorectal cancer (mCRC): Hoosier Oncology Group GI05-102—Final report.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 3587-3587 ◽  
Author(s):  
S. Shahda ◽  
M. Yu ◽  
J. Picus ◽  
J. A. Bufill ◽  
W. A. Harb ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Phase I ◽  
Metastatic Colorectal Cancer ◽  
Phase I Study ◽  
Final Report ◽  
Second Line ◽  
Oncology Group

Results from a phase I study of andecaliximab in combination with FOLFIRI and bevacizumab in patients with second line metastatic colorectal cancer.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 3578-3578
Author(s):  
Zev A. Wainberg ◽  
Johanna C. Bendell ◽  
Heinz-Josef Lenz ◽  
Ari David Baron ◽  
Jordan Berlin ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Phase I ◽  
Metastatic Colorectal Cancer ◽  
Phase I Study ◽  
Second Line

scholarly journals Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer

2015 ◽  
Vol 112 (12) ◽  
pp. 1874-1881 ◽  
Author(s):  
T Macarulla ◽  
A Cervantes ◽  
J Tabernero ◽  
S Roselló ◽  
E Van Cutsem ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Phase I ◽  
Metastatic Colorectal Cancer ◽  
Phase I Study ◽  
Line Treatment ◽  
Second Line

scholarly journals First report of a Japanese phase I study of triplet plus bevacizumab for chemotherapy-naive metastatic colorectal cancer (J1-TRIBE study)

2015 ◽  
Vol 4 ◽  
pp. 75-80 ◽  
Author(s):  
Hironaga Satake ◽  
Akihito Tsuji ◽  
Takeshi Kotake ◽  
Yoshihiro Okita ◽  
Yukimasa Hatachi
Keyword(s):  
Colorectal Cancer ◽  
Phase I ◽  
Metastatic Colorectal Cancer ◽  
Phase I Study ◽  
First Report

scholarly journals Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a Phase I study

2007 ◽  
Vol 96 (1) ◽  
pp. 38-43 ◽  
Author(s):  
H Y Sheikh ◽  
J W Valle ◽  
K Palmer ◽  
A Sjursen ◽  
O Craven ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Phase I ◽  
Metastatic Colorectal Cancer ◽  
Phase I Study ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

Sequential Treatment with Irinotecan and Doxifluridine: Optimal Dosing Schedule in Murine Models and in a Phase I Study for Metastatic Colorectal Cancer

Chemotherapy ◽  
2005 ◽  
Vol 51 (1) ◽  
pp. 32-39 ◽  
Author(s):  
Hideyuki Mishima ◽  
Takeshi Kato ◽  
Mieko Yanagisawa ◽  
Toshimasa Tsujinaka ◽  
Isamu Nishisho ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Phase I ◽  
Metastatic Colorectal Cancer ◽  
Phase I Study ◽  
Sequential Treatment ◽  
Murine Models ◽  
Dosing Schedule ◽  
Optimal Dosing

scholarly journals 174P Japanese phase I study of triplet plus bevacizumab for chemotherapy-naive metastatic colorectal cancer (J1-TRIBE study)

2015 ◽  
Vol 26 ◽  
pp. ix42
Author(s):  
H. Satake ◽  
A. Tsuji ◽  
Y. Hatachi ◽  
T. Kotake ◽  
Y. Okita ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Phase I ◽  
Metastatic Colorectal Cancer ◽  
Phase I Study
Sign in / Sign up

Export Citation Format

Share Document